{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:32:52Z","timestamp":1793734372232,"version":"4.6.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-025618"],"award-info":[{"award-number":["MJFF-025618"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ebiom.2025.105925","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:10:48Z","timestamp":1758611448000},"page":"105925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["\u03b1-Synuclein seed amplification assay positivity beyond synucleinopathies"],"prefix":"10.1016","volume":"120","author":[{"given":"Ivan","family":"Martinez-Valbuena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fullam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"O\u2019Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","article-title":"Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid","volume":"18","author":"Concha-Marambio","year":"2023","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105925_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105925_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","article-title":"Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study","volume":"23","author":"Ma","year":"2024","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pathol.2024.10.006","article-title":"Current concepts and molecular pathology of neurodegenerative diseases","volume":"57","author":"Forrest","year":"2025","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/cjn.2022.34","article-title":"Current concepts of mixed pathologies in neurodegenerative diseases","volume":"50","author":"Forrest","year":"2023","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib6","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/alz.13658","article-title":"Investigating alpha-synuclein co-pathology in Alzheimer\u2019s disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay","volume":"20","author":"Bellomo","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105925_bib7","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41591-023-02449-7","article-title":"Clinical effects of Lewy body pathology in cognitively impaired individuals","volume":"29","author":"Quadalti","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105925_bib8","series-title":"Greenfield\u2019s neuropathology","first-page":"803","article-title":"Neurodegenerative diseases: classification","author":"Kovacs","year":"2025"},{"issue":"7933","key":"10.1016\/j.ebiom.2025.105925_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"7825","key":"10.1016\/j.ebiom.2025.105925_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105925_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00401-023-02550-8","article-title":"New SNCA mutation and structures of \u03b1-synuclein filaments from juvenile-onset synucleinopathy","volume":"145","author":"Yang","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s42003-025-08355-7","article-title":"Lewy-MSA hybrid fold drives distinct neuronal \u03b1-synuclein pathology","volume":"8","author":"Enomoto","year":"2025","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","article-title":"Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy","volume":"11","author":"Martinez-Valbuena","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105925_bib15","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study","volume":"141","author":"Attems","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2025.105925_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","article-title":"Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread","volume":"69","author":"Kovacs","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","article-title":"Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy","volume":"33","author":"Trojanowski","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105925_bib19","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/mds.30028","article-title":"Biomarker-based approach to alpha-Synucleinopathies: lessons from neuropathology","volume":"39","author":"Kovacs","year":"2024","journal-title":"Mov Disord"},{"key":"10.1016\/j.ebiom.2025.105925_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-019-0172-x","article-title":"Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities","volume":"8","author":"Visanji","year":"2019","journal-title":"Transl Neurodegener"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/WCO.0000000000000664","article-title":"Are comorbidities compatible with a molecular pathological classification of neurodegenerative diseases?","volume":"32","author":"Kovacs","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105925_bib22","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105925_bib23","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"issue":"21","key":"10.1016\/j.ebiom.2025.105925_bib24","doi-asserted-by":"crossref","first-page":"e2472","DOI":"10.1212\/WNL.0000000000007530","article-title":"Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration","volume":"92","author":"Forrest","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105925_bib25","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamaneurol.2021.1813","article-title":"Association between globular glial tauopathies and frontotemporal dementia-expanding the spectrum of gliocentric disorders: a review","volume":"78","author":"Forrest","year":"2021","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000439251","article-title":"Clinicopathological correlations and concomitant pathologies in rapidly progressive dementia: a brain bank series","volume":"15","author":"Grau-Rivera","year":"2015","journal-title":"Neurodegener Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105925_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/NEN.0b013e3181abdae8","article-title":"The nigrostriatal pathway in Creutzfeldt-Jakob disease","volume":"68","author":"Vital","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/mds.29670","article-title":"Frequency of comorbid pathologies and their clinical impact in multiple system atrophy","volume":"39","author":"Sekiya","year":"2024","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnen\/nlw002","article-title":"Altered proteins in the aging brain","volume":"75","author":"Elobeid","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105925_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","article-title":"Lewy body pathology in normal elderly subjects","volume":"68","author":"Markesbery","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/nan.12362","article-title":"Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type","volume":"43","author":"Brettschneider","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","article-title":"Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series","volume":"126","author":"Kovacs","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2025.105925_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.70024","article-title":"Contribution of \u03b1-synuclein cytopathologies to distinct seeding of misfolded \u03b1-synuclein","author":"Kim","year":"2025","journal-title":"Brain Pathol"},{"issue":"10452","key":"10.1016\/j.ebiom.2025.105925_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105925_bib35","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1002\/alz.13109","article-title":"CSF alpha-synuclein aggregates by seed amplification and clinical presentation of AD","volume":"19","author":"Pilotto","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib36","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1038\/s41467-024-52299-1","article-title":"Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer\u2019s disease","volume":"15","author":"Collij","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105925_bib37","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1002\/alz.13858","article-title":"A cross-sectional study of \u03b1-synuclein seed amplification assay in Alzheimer\u2019s disease neuroimaging initiative: prevalence and associations with Alzheimer\u2019s disease biomarkers and cognitive function","volume":"20","author":"Tosun","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105925_bib38","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/awaf037","article-title":"The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients","volume":"148","author":"Silva-Rodr\u00edguez","year":"2025","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105925_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","article-title":"Clinical features of Alzheimer disease with and without Lewy bodies","volume":"72","author":"Chung","year":"2015","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105925_bib41","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1002\/alz.13799","article-title":"Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort","volume":"20","author":"Samudra","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.26453","article-title":"\u03b1-Synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological \u03b1-Synuclein in the context of Co-Pathology and Non-LBD diagnoses","volume":"92","author":"Arnold","year":"2022","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-022-01388-7","article-title":"Performance of \u03b1Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease","volume":"10","author":"Hall","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105925_bib45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib46","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1038\/s41467-024-49402-x","article-title":"Disease progression modelling reveals heterogeneity in trajectories of Lewy-type \u03b1-synuclein pathology","volume":"15","author":"Mastenbroek","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3233\/JAD-170914","article-title":"Influence of Lewy pathology on Alzheimer\u2019s disease phenotype: a retrospective clinico-pathological study","volume":"63","author":"Roudil","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.ebiom.2025.105925_bib49","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105925_bib50","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105925_bib51","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1002\/alz.14276","article-title":"Association of CSF \u03b1-synuclein seed amplification assay positivity with disease progression and cognitive decline: a longitudinal Alzheimer\u2019s disease neuroimaging initiative study","volume":"20","author":"Tosun","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"17","key":"10.1016\/j.ebiom.2025.105925_bib52","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.0000000000004567","article-title":"Mixed neuropathologies and associations with domain-specific cognitive decline","volume":"89","author":"Brenowitz","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib53","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/alz.13609","article-title":"Individuals with Alzheimer\u2019s disease and low tau burden: characteristics and implications","volume":"20","author":"Landau","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib54","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1002\/alz.13818","article-title":"\u03b1-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer\u2019s disease late in the disease course and dependent on Lewy pathology burden","volume":"20","author":"Levin","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100040","article-title":"Distinct CSF \u03b1-synuclein aggregation profiles associated with Alzheimer\u2019s disease phenotypes and MCI-to-AD conversion","volume":"12","author":"Ding","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib56","article-title":"Comorbid neuropathology and atypical presentation of Alzheimer\u2019s disease","volume":"16","author":"Pina-Escudero","year":"2024","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7794","key":"10.1016\/j.ebiom.2025.105925_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105925_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.737195","article-title":"The concept of \u03b1-Synuclein strains and how different conformations may explain distinct neurodegenerative disorders","volume":"12","author":"Malfertheiner","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","article-title":"Evidence of distinct \u03b1-synuclein strains underlying disease heterogeneity","volume":"142","author":"Holec","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2025.105925_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.907293","article-title":"Alpha-synuclein strain variability in body-first and brain-first synucleinopathies","volume":"14","author":"Just","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnen\/nlx099","article-title":"The amygdala as a locus of pathologic misfolding in neurodegenerative diseases","volume":"77","author":"Nelson","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","article-title":"Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression","volume":"7","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-025-00822-3","article-title":"Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer\u2019s disease","volume":"20","author":"Franzmeier","year":"2025","journal-title":"Mol Neurodegener"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105925_bib64","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","article-title":"Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease","volume":"30","author":"Jack","year":"2024","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105925_bib65","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00415-025-12978-5","article-title":"Skin \u03b1-synuclein assays in diagnosing Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"272","author":"Zhao","year":"2025","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib66","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","article-title":"Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies","volume":"29","author":"Okuzumi","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib67","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnen\/nlz141","article-title":"Primary tau pathology, not copathology, correlates with clinical symptoms in PSP and CBD","volume":"79","author":"Robinson","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib68","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mds.28011","article-title":"Copathology in progressive supranuclear palsy: does it matter?","volume":"35","author":"Jecmenica Lukic","year":"2020","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib69","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209818","article-title":"CSF \u03b1-Synuclein seed amplification assay in patients with atypical parkinsonian disorders","volume":"103","author":"Anastassiadis","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2025.105925_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105807","article-title":"\u03b1-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders","volume":"117","author":"Fernandes Gomes","year":"2023","journal-title":"Parkinson Relat Disord"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105925_bib71","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/mds.30019","article-title":"Evaluation of cerebrospinal fluid \u03b1-Synuclein seed amplification assay in progressive supranuclear palsy and corticobasal syndrome","volume":"39","author":"Vaughan","year":"2024","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-019-02080-2","article-title":"4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration","volume":"139","author":"Saijo","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105925_bib73","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaneurol.2024.3162","article-title":"Four-repeat tau seeding in the skin of patients with progressive supranuclear palsy","volume":"81","author":"Martinez-Valbuena","year":"2024","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-510X(65)90016-X","article-title":"The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics","volume":"2","author":"Hakim","year":"1965","journal-title":"J Neurol Sci"},{"issue":"3 Suppl","key":"10.1016\/j.ebiom.2025.105925_bib75","first-page":"S4","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105925_bib76","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000000342","article-title":"Prevalence of idiopathic normal-pressure hydrocephalus","volume":"82","author":"Jaraj","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib77","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-181012","article-title":"Revisiting the cerebrospinal fluid biomarker profile in idiopathic normal pressure hydrocephalus: the Bologna pro-hydro study","volume":"68","author":"Abu-Rumeileh","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12987-022-00306-2","article-title":"Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus","volume":"19","author":"Braun","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12987-022-00309-z","article-title":"Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients","volume":"19","author":"Lukkarinen","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ebiom.2025.105925_bib80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2017.03.012","article-title":"Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson\u2019s disease","volume":"55","author":"Mak","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib81","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mds.28366","article-title":"Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus","volume":"36","author":"Pozzi","year":"2021","journal-title":"Mov Disord"},{"issue":"23","key":"10.1016\/j.ebiom.2025.105925_bib82","doi-asserted-by":"crossref","first-page":"e2861","DOI":"10.1212\/WNL.0000000000012064","article-title":"Clinical outcome and striatal dopaminergic function after shunt surgery in patients with idiopathic normal pressure hydrocephalus","volume":"96","author":"Todisco","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12987-022-00368-2","article-title":"In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome","volume":"19","author":"Giannini","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib84","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ana.26505","article-title":"Alpha-synuclein RT-QuIC in idiopathic normal pressure hydrocephalus","volume":"92","author":"Fasano","year":"2022","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib85","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mds.30184","article-title":"Anosmia and upper limb Rigidity-A potential phenotype of idiopathic normal pressure hydrocephalus with cerebrospinal fluid \u03b1-Synuclein seeds","volume":"40","author":"Weber","year":"2025","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105925_bib86","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00415-017-8598-5","article-title":"Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study","volume":"264","author":"Molde","year":"2017","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105925_bib87","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jalz.2010.12.008","article-title":"Frequency of Alzheimer\u2019s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus","volume":"7","author":"Cabral","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-019-0748-9","article-title":"Alzheimer\u2019s disease neuropathological change and loss of matrix\/neuropil in patients with idiopathic normal pressure hydrocephalus, a model of Alzheimer\u2019s disease","volume":"7","author":"Libard","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105925_bib89","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib90","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2045-8118-10-22","article-title":"Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH","volume":"10","author":"Malm","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp.2006.095117","article-title":"Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting","volume":"78","author":"Bech-Azeddine","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib92","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.68.6.778","article-title":"Alzheimer\u2019s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response","volume":"68","author":"Golomb","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20134","key":"10.1016\/j.ebiom.2025.105925_bib93","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000335155","article-title":"Cortical brain biopsy in long-term prognostication of 468 patients with possible normal pressure hydrocephalus","volume":"10","author":"Leinonen","year":"2012","journal-title":"Neurodegener Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.22015","article-title":"Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology","volume":"68","author":"Hamilton","year":"2010","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib95","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.22100","article-title":"Amyloid and tau proteins in cortical brain biopsy and Alzheimer\u2019s disease","volume":"68","author":"Leinonen","year":"2010","journal-title":"Ann Neurol"},{"issue":"10248","key":"10.1016\/j.ebiom.2025.105925_bib96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the lancet commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105925_bib97","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnen\/nly065","article-title":"Lewy body pathology and chronic traumatic encephalopathy associated with contact sports","volume":"77","author":"Adams","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib98","article-title":"Associations between concussion and risk of diagnosis of psychological and neurological disorders: a retrospective population-based cohort study","volume":"8","author":"Morissette","year":"2020","journal-title":"Fam Med Community Health"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105925_bib99","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","article-title":"Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings","volume":"73","author":"Crane","year":"2016","journal-title":"JAMA Neurol"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105925_bib100","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1908483","article-title":"Neurodegenerative disease mortality among former professional soccer players","volume":"381","author":"Mackay","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib101","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9311","article-title":"Association of traumatic brain injury with and without loss of consciousness with neuropathologic outcomes in community-dwelling older persons","volume":"5","author":"Agrawal","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2025.105925_bib102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000369787","article-title":"Interactions between traumatic brain injury and frontotemporal degeneration","volume":"39","author":"Deutsch","year":"2015","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16259","article-title":"Unusual combinations of neurodegenerative pathologies with chronic traumatic encephalopathy (CTE) complicates clinical prediction of CTE","volume":"31","author":"Taghdiri","year":"2024","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib104","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnen\/nlab001","article-title":"The second NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy","volume":"80","author":"Bieniek","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"issue":"17\u201318","key":"10.1016\/j.ebiom.2025.105925_bib105","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/neu.2022.0060","article-title":"Multi-modal biomarkers of repetitive head impacts and traumatic encephalopathy syndrome: a clinicopathological case series","volume":"39","author":"Asken","year":"2022","journal-title":"J Neurotrauma"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-017-1680-3","article-title":"Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players","volume":"133","author":"Ling","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib107","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2017.8334","article-title":"Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football","volume":"318","author":"Mez","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.ebiom.2025.105925_bib108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fneur.2020.00042","article-title":"A clinicopathological report of a 93-Year-Old former street boxer with coexistence of chronic traumatic encephalopathy, Alzheimer\u2019s disease, dementia with Lewy bodies, and hippocampal sclerosis with TDP-43 pathology","volume":"11","author":"Yang","year":"2020","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/neup.70004","article-title":"Unprecedented combination of rare degenerative pathologies in an octogenarian Ex-Football player","volume":"45","author":"Forrest","year":"2025","journal-title":"Neuropathology"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105925_bib110","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/mds.29621","article-title":"Misfolded \u03b1-Synuclein in cerebrospinal fluid of contact sport athletes","volume":"38","author":"Vasilevskaya","year":"2023","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib111","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","article-title":"The development and convergence of co-pathologies in Alzheimer\u2019s disease","volume":"144","author":"Robinson","year":"2021","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib112","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"Hoglinger","year":"2024","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib113","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105925_bib114","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-023-02631-8","article-title":"Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab","volume":"146","author":"VandeVrede","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib116","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/STROKEAHA.121.036873","article-title":"Vessels sing their ARIAs: the role of vascular amyloid in the age of aducanumab","volume":"53","author":"Sveikata","year":"2022","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib117","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib118","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib119","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13195-022-01150-0","article-title":"Alpha-synuclein: a pathological factor with A\u03b2 and tau and biomarker in Alzheimer\u2019s disease","volume":"14","author":"Shim","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2025.105925_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.559791","article-title":"In search of effective treatments targeting \u03b1-Synuclein toxicity in synucleinopathies: pros and cons","volume":"8","author":"Fouka","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib121","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105925_bib122","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105925_bib123","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib124","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 pathology in Alzheimer\u2019s disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105925_bib125","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1084\/jem.20181737","article-title":"Targeting neuro-immune communication in neurodegeneration: challenges and opportunities","volume":"215","author":"Deczkowska","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2025.105925_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105925_bib127","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.26428","article-title":"Combination therapies: the next logical step for the treatment of synucleinopathies?","volume":"31","author":"Valera","year":"2016","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib128","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2025.105925_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106080","article-title":"Anti-alpha synuclein and anti-tau immunotherapies: can a cocktail approach work?","volume":"122","author":"Del Giudice","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105925_bib130","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70165","article-title":"High agreement across laboratories between different alpha-synuclein seed amplification protocols","volume":"32","author":"Br\u00e4uer","year":"2025","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib131","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3233\/JAD-230919","article-title":"Misfolded \u03b1-Synuclein in autosomal dominant Alzheimer\u2019s disease","volume":"97","author":"Fort-Aznar","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105925_bib132","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312031121","article-title":"Toward the quantification of \u03b1-synuclein aggregates with digital seed amplification assays","volume":"121","author":"Gilboa","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13024-024-00781-1","article-title":"Seeding activity of skin misfolded tau as a biomarker for tauopathies","volume":"19","author":"Wang","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib134","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41531-024-00728-9","article-title":"Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies","volume":"10","author":"Dellarole","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.ebiom.2025.105925_bib135","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2025.1630","article-title":"Copathology in atypical parkinsonism-the rule rather than the exception?","author":"Martinez-Valbuena","year":"2025","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105925_bib136","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","article-title":"The \u03b1-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases","volume":"14","author":"Smith","year":"2023","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105925_bib137","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1016\/j.cell.2023.06.004","article-title":"Development of an \u03b1-synuclein positron emission tomography tracer for imaging synucleinopathies","volume":"186","author":"Xiang","year":"2023","journal-title":"Cell"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500369X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500369X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:37:48Z","timestamp":1772905068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500369X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":137,"alternative-id":["S235239642500369X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105925","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Synuclein seed amplification assay positivity beyond synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105925"}}